Bioniche Life Sciences Inc. Reports Q2, Fiscal 2013 Results

BELLEVILLE, ON, Feb. 6, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the second quarter of its 2013 fiscal year (ended December 31, 2012).

MORE ON THIS TOPIC